1Barrit DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet, 1960, 18;1:1309-1312.
2Arcasoy SM, Vachani A. Local and systemic thrombolytic therapy for acute venous thromboembolism. Clin Chest Med,2003,24( 1 ) :73-91.
3Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al. Streptokinase and Heparin versus Heparin Alone in Massive Pulmonary Embolism: A Randomized Controlled Trial. J Thromb Thrombolysis, 1995,2(3) :227-229.
4Konstantinides S, Geibel A, Heusel G, et al. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med, 2002,347 (15) : 1143-1150.
6Dalla-Voha S, Palla A, Santolicandro A, et al. lstituto di Cardiologia,Universita di Padova, Italy. PALMS 2 : alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian muhicenter study 2. J Am Coll Cardiol, 1992,20( 3 ) :520-526.
